BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 27223846)

  • 1. Modeling the cost-effectiveness of ilaprazole versus omeprazole for the treatment of newly diagnosed duodenal ulcer patients in China.
    Xuan JW; Song RL; Xu GX; Lu WQ; Lu YJ; Liu Z
    J Med Econ; 2016 Nov; 19(11):1056-1060. PubMed ID: 27223846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ilaprazole for the treatment of duodenal ulcer: a randomized, double-blind and controlled phase III trial.
    Wang L; Zhou L; Hu H; Lin S; Xia J
    Curr Med Res Opin; 2012 Jan; 28(1):101-9. PubMed ID: 22070512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ilaprazole based bismuth-containing quadruple regimen for the first-line treatment of Helicobacter pylori infection: a multicenter, randomized, controlled clinical study].
    Gao W; Cheng H; Hu FL; Lü NH; Xie Y; Sheng JQ; Xu JM; Zhang LX; Zhang L; Chen Y; Zhang ZY; Zhang GX; Cui MH; Yang GB; Gao HJ; Yang L
    Zhonghua Yi Xue Za Zhi; 2012 Aug; 92(30):2108-12. PubMed ID: 23158273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ilaprazole: Is this a superior proton pump inhibitor for duodenal ulcer?
    Bohidar NP; Krishna K; Panda BK; Patel C
    Trop Gastroenterol; 2013; 34(2):95-8. PubMed ID: 24377157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of the effect of ilaprazole on intragastric pH in patients with duodenal ulcer].
    Zhou LY; Lin SR; Yang YS; Zhang ST; Yuan YZ; Shi RH; Hou XH; Xia JL; Hu HT; Qin XH
    Zhonghua Nei Ke Za Zhi; 2010 Apr; 49(4):290-2. PubMed ID: 20627032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of CYP2C19 genetic polymorphisms on the efficacy of proton pump inhibitor-based triple therapy for Helicobacter pylori eradication: a meta-analysis.
    Zhao F; Wang J; Yang Y; Wang X; Shi R; Xu Z; Huang Z; Zhang G
    Helicobacter; 2008 Dec; 13(6):532-41. PubMed ID: 19166419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of ilaprazole in the treatment of duodenal ulcers: a meta-analysis.
    Ji XQ; Du JF; Chen G; Chen G; Yu B
    World J Gastroenterol; 2014 May; 20(17):5119-23. PubMed ID: 24803828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin.
    Furuta T; Shirai N; Takashima M; Xiao F; Hanai H; Sugimura H; Ohashi K; Ishizaki T; Kaneko E
    Clin Pharmacol Ther; 2001 Mar; 69(3):158-68. PubMed ID: 11240980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness analysis of Anaprazole versus Ilaprazole for the treatment of duodenal ulcers in China.
    Ni H; Shi J; Hu M; Zhou N; Yang S
    Front Pharmacol; 2024; 15():1407435. PubMed ID: 38910891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of treatment regimens for the eradication of Helicobacter pylori in duodenal ulcer.
    Vakil N; Fennerty MB
    Am J Gastroenterol; 1996 Feb; 91(2):239-45. PubMed ID: 8607487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of omeprazole dosage and cytochrome P450 2C19 genotype in patients receiving omeprazole-amoxicillin dual therapy for Helicobacter pylori eradication.
    Yang JC; Wang HL; Chern HD; Shun CT; Lin BR; Lin CJ; Wang TH
    Pharmacotherapy; 2011 Mar; 31(3):227-38. PubMed ID: 21361732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-week therapy with omeprazole, clarithromycin and metronidazole or ornidazole, followed by 3 weeks' treatment with omeprazole, eradicates Helicobacter pylori equally and heals duodenal ulcer.
    Tzivras M; Archimandritis A; Balatsos V; Delis V; Souyioultzis S; Skandalis N; Kanellopoulou E; Manika Z; Davaris P
    Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1185-9. PubMed ID: 9471024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic therapy of Helicobacter pylori infection reduces healthcare expenditures related to duodenal ulcer.
    Sonnenberg A; Pauly MP; Levenson SD; Schwartz JS
    Am J Manag Care; 1999 Jan; 5(1):53-9. PubMed ID: 10345967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term consequences with regard to clinical outcome and cost-effectiveness of episodic treatment with omeprazole or ranitidine for healing of duodenal ulcer.
    Walan A; Eriksson S
    Scand J Gastroenterol Suppl; 1994; 201():91-7. PubMed ID: 8047832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of triple therapy or amoxycillin plus omeprazole or amoxycillin plus tinidazole plus omeprazole on duodenal ulcer healing, eradication of Helicobacter pylori, and prevention of ulcer relapse over a 1-year follow-up period: a prospective, randomized, controlled study.
    Saberi-Firoozi M; Massarrat S; Zare S; Fattahi M; Javan A; Etaati H; Dehbashi N
    Am J Gastroenterol; 1995 Sep; 90(9):1419-23. PubMed ID: 7661161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the cost of maintenance therapy (6 months) with 150 mg ranitidine vs 20 mg omeprazole vs 20 mg omeprazole every other day in duodenal ulcer].
    Di Mario F; Grasso GA; Battaglia G; De Boni M; Vianello F; De Bona M; Pasquino M; Chiozzini G; Saggioro A
    Minerva Gastroenterol Dietol; 1993 Jun; 39(2):83-7. PubMed ID: 8364105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms and the pocketbook: the cost-effectiveness of cytochrome P450 2C19 genotyping in the eradication of Helicobacter pylori infection associated with duodenal ulcer.
    Lehmann DF; Medicis JJ; Franklin PD
    J Clin Pharmacol; 2003 Dec; 43(12):1316-23. PubMed ID: 14615467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of Helicobacter pylori eradication therapy in duodenal ulcer disease.
    Jönsson B
    Scand J Gastroenterol Suppl; 1996; 215():90-5. PubMed ID: 8722390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic Evaluation of Safflower Yellow Injection for the Treatment of Patients with Stable Angina Pectoris in China: A Cost-Effectiveness Analysis.
    Xuan J; Huang M; Lu Y; Tao L
    J Altern Complement Med; 2018 Jun; 24(6):564-569. PubMed ID: 29431470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standard-Dose Proton Pump Inhibitors in the Initial Non-eradication Treatment of Duodenal Ulcer: Systematic Review, Network Meta-Analysis, and Cost-Effectiveness Analysis.
    Zhang J; Ge L; Hill M; Liang Y; Xie J; Cui D; Li X; Zheng W; He R
    Front Pharmacol; 2018; 9():1512. PubMed ID: 30666204
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.